(SYNRIBO is registered trademarks TEVA PHARMACEUTICALS USA, INC.)
Synribo – Omacetaxine Mepesuccinate 3.5 mg is supplied for Tenders, Emergency imports, Orphan drug, Reference listed drugs, Comparator Drug, Name patient medicine and Innovator samples etc.
What is SYNRIBO:
SYNRIBO is a medicine that contains the active substance Omacetaxine Mepesuccinate and is available as Single-Use Vial.
In how many countries SYNRIBO is approved for marketing?
SYNRIBO is available/approved in USA and Europe. We can help you to access it in India.
What is SYNRIBO used for?
SYNRIBO is indicated for the treatment of adult patients with chronic or accelerated phase chronic myeloid leukemia (CML) with resistance and/or intolerance to two or more tyrosine kinase inhibitors (TKI).
How can I get SYNRIBO in India?
SYNRIBO is a prescription only drug and is not approved for marketing in India.
The Indian Pharma (IP) is a consulting pharmaceutical company which assists Patients in accessing medicines in India. The Indian Pharma facilitates such access only against valid prescriptions in conformity with all local laws and regulations.
Patients/ Clinicians / Researchers can contact IP at +91-120-4080562 or write to at – email@example.com
We facilitate by-
- Helping in documentation to import the medicine for personal use
- Finding Genuine and reliable source in USA, Europe and Japan
- Ensuring 100% transparency.
SYNRIBO can be shipped to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Jaipur, Lucknow, Cochin and Pune and other cities in India.
The Indian Pharma can facilitate the supply of SYNRIBO (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement.
The Indian Pharma does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturers or licensees
Can I get SYNRIBO even if I am not based in India?
Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country
The Indian Pharma (IP) can help patients in accessing/importing SYNRIBO, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.
Send your enquiry to find-
- SYNRIBO in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
- SYNRIBO in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
- SYNRIBO in North America – Mexico.
- SYNRIBO in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
- SYNRIBO in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
- SYNRIBO in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
- SYNRIBO in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
- SYNRIBO in Australia and New Zealand.